शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
BSETRANSGENE BIOTEK LTD.· Healthcare ServicesHighNegative
Announced Wed, 4 Nov, 2026 · 13:58 IST

Statutory auditor Harish Gummadi and Co resigns before term completion

Auditor resigned mid-termManagement Changes View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+7.1%Reaction day
₹2.40
prior close
₹2.57
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+2.2%+4.9% vs market
Healthcare Service Provider peers, median of 27sector+1.6%+5.5% vs sector

On the reaction day the stock moved 4.9 pts more than Nifty Microcap 250 and 5.5 pts more than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
+0.0
15m
+0.0
30m
+0.0
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+7.1+2.2+4.9+1.6+5.5
Next day
+6.3pendingpending+0.8+5.5
2d
———+0.0—
3d
—————
4d
—————
5d
—————
1w
—————
15d
—————
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Healthcare Service Provider peers, median of 27Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Statutory auditor Harish Gummadi and Co resigned effective 3 November 2026, before its term at the next annual meeting. It cited an unforeseen family medical emergency and insufficient time and resources. Appointed on 2 November 2026 to fill a vacancy, the firm had issued no audit or quarterly review report and could not complete the 30 September 2026 quarter review by 14 November. The company will appoint a new auditor.

Likely market impact

A new auditor is needed promptly to complete the September quarter review, creating some near-term reporting risk. No audit concerns were reported.